Determination of antipyrine sulphoconjugates in isolated cultured rat hepatocytes

References

• Baessman H., Boettcher J., Schueppel R. Isolation and characterization of the four antipyrine glucuronides and determination of their urinary excretion pattern in man by a reversed-phase h.p.l.c. assay. Xenobiotica 1985; 15: 941–952
   PubMed Web of Science ®Google Scholar
• Boettcher J., Baessman H., Schueppel R. Quantitation and urinary pattern of 4,4′-dihydroxyantipyrine, 4-hydroxyantipyrine and 3-hydroxymethylantipyrine as main metabolites of antipyrine in man and rat. Journal of Pharmaceutical Pharmacology 1982a; 34: 168–175
   PubMedGoogle Scholar
• Boettcher J., Baessman H., Schuppel R., Lehmann W. D. Preparative isolation and purification of urinary conjugates in antipyrine metabolism in man and rat. Naunyn-Schmiedeberg's Archives of Pharmacology 1982b; 321: 226–233
   PubMed Web of Science ®Google Scholar
• Boettcher J., Baessman H., Schueppel R. Identification of sulphates in antipyrine metabolism in man, rat and rabbit. Drug Metabolism and Disposition 1982c; 10: 90–91
   PubMed Web of Science ®Google Scholar
• Boettcher J., Baessman H., Schueppel R. Quantitation of norantipyrine sulphate and norantipyrine glucuronide as major metabolites of antipyrine in man and rat. Journal of Pharmaceutical Pharmacology 1984; 36: 391–398
   PubMed Web of Science ®Google Scholar
• Bradford M. M. Simple and sensitive protein assay. Analytical Biochemistry 1976; 72: 248
   PubMed Web of Science ®Google Scholar
• Buppodom P., Koga N., Yamada H., Yoshimura H. Studies on rat liver cytochrome P-450 S involved in the metabolism of antipyrine: phenobarbital and 3-methylcholanthrene inducible isoenzymes possessing 4-hydroxylase activity. Biochemical Pharmacology 1986; 35: 1404–1406
   PubMed Web of Science ®Google Scholar
• Chenery R. J., Oldham H. G., Standring P., Norman S. J., Jennings P., Mason P. A. Antipyrine metabolism in cultured rat hepatocytes. Biochemical Pharmacology 1987; 36: 3077–3081
   PubMed Web of Science ®Google Scholar
• Danhof M., De Groot-Van Der Vis E., Breimer D. D. Assay of antipyrine and its primary metabolites in plasma, saliva and urine by H.P.L.C. and some preliminary result in man. Pharmacology 1979; 18: 210–223
   PubMed Web of Science ®Google Scholar
• Danhof M., Teunissen M. W. E., Breimer D. D. 3-hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. Pharmacology 1982a; 24: 181–184
   PubMed Web of Science ®Google Scholar
• Danhof M., Verbeek R. M. A., Van Boxtel C. J., Boeijing J. K., Breimer D. D. Differential effects of enzyme induction on antipyrine metabolite formation. British Journal of Clinical Pharmacology 1982b; 13: 379–386
   PubMed Web of Science ®Google Scholar
• Eichelbaum M., Sonntag B., Dengler H. J. Determination of antipyrine metabolites. Pharmacology 1981; 23: 192–202
   PubMed Web of Science ®Google Scholar
• Kahn G. C., Boobis A. R., Murray S., Davies D. S. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver. Xenobiotica 1982; 12: 509–516
   PubMed Web of Science ®Google Scholar
• Loft S., Poulsen H. E. Metabolism of metronidazole and antipyrine in isolated rat hepatocytes. Influence of sex and enzyme induction and inhibition. Biochemical Pharmacology 1989; 38: 1125–1136
   PubMed Web of Science ®Google Scholar
• Loft S., Poulsen H. E. Metabolism of metronidazole and antipyrine in hepatocytes isolated from mouse and rat. Xenobiotica 1990; 20: 185–191
   PubMed Web of Science ®Google Scholar
• Loft S. Metronidazole and antipyrine as probe for the study of foreign compound metabolism. Pharmacology and Toxicology 1990; V66–SVI
   Google Scholar
• Marceau N., Baribault H., Germain L., Noel M. Le cytosquelette des hépatocytes en culture, in 'Recherrche en.'. Hépatocytes isolés et en culture, A. Guillouzo, C. Guguen-Guillouzo, J. Inserm, Libbey, 41–65
   Google Scholar
• McManus M. E., Ilett K. F. Comparison of rate of hepatic metabolism in vitro and half-life for antipyrine in vivo in three species. Xenobiotica 1979; 9: 107–118
   PubMed Web of Science ®Google Scholar
• Nagawaka A., Nakamura K. I. Automated H.P.L.C. method for the determination of antipyrine and its metabolites in urine. Some preliminary results obtained from smokers and non smokers. Journal of Chromatography 1982; 231: 349–360
   PubMed Web of Science ®Google Scholar
• Onhaus E. E., Brockmeyer N., Dylewicz P., Habicht H. The effect of antipyrine and rifampicine on the metabolism of diazepam. Clinical Pharmacology and Therapeutics 1987; 42: 148–156
   PubMed Web of Science ®Google Scholar
• Paigen B., Ward E., Steenland K., Bolanowska W., Gessner T., Chang R. L., Wood A. W., Conney A. H. Absence of seasonal variation in antipyrine metabolism. Clinical Pharmacology and Therapeutics 1982; 31: 144–150
   PubMed Web of Science ®Google Scholar
• Pays C. Le dosage des métabolites de l'antipyrine. Application à l'étude du métabolisme oxidatif des médicaments. Mémoire de stage pour l'obtention du Diplôme d'Etude Approfondie de Pharmacologie Clinique et Expérimentale, Université Paris 1988; VI
   Google Scholar
• Seglen P. O. Preparation of rat liver cells. III. Enzymatic requirement for tissue dispersion. Experimental Cell Research 1973; 82: 391–398
   PubMed Web of Science ®Google Scholar
• Shaw P. N., Houston J. B., Rowland M., Hopkins K., Thiercelin J. F. Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepin. British Journal of Clinical Pharmacology 1985; 20: 611–618
   PubMed Web of Science ®Google Scholar
• Tanaka E., Nakamura K. Comparison of trimethadione and antipyrine as indicators of oxidative drug metabolizing capacity in man. European Journal of Clinical Pharamcology 1989; 36: 629–632
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Meerburg-Van Der Torren J. E., Vermeulen N. P. E., Breimer D. D. Automated H.P.L.C. determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4–4′-dihydroxyantipyrine. Journal of Chromatography 1983; 278: 367–378
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Bakker W., Meerburg-Van Der Torren J. E., Breimer D. D. Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis. British Journal of Clinical Pharmacology 1984a; 18: 701–706
   PubMed Web of Science ®Google Scholar
• Teunissen M. W. E., Willemse P. H. B., Sleijfer D. J., Sluiter W. J., Breimer D. D. Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment. Cancer Chemotherapy and Pharmacology 1984b; 13: 181–185
   PubMed Web of Science ®Google Scholar
• Vessel E. S. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286
   PubMed Web of Science ®Google Scholar